Delves, P.J., and I.M. Roitt. 2000. The immune system. Second of two parts. N Engl J Med. 343:108-17.

Delves, P.J., and I.M. Roitt. 2000. The immune system. First of two parts. N Engl J Med. 343:37-49.

Medzhitov, R., and C. Janeway, Jr. 2000. Innate immunity. N Engl J Med. 343:338-44.

Krieg, A.M., L. Love-Homan, A.K. Yi, and J.T. Harty. 1998. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol. 161:2428-34.

Beutler, B., and A. Poltorak. 2000. Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur Cytokine Netw. 11:143-52.

Gay, N.J., and F.J. Keith. 1991. Drosophila Toll and IL-1 receptor [letter]. Nature. 351:355-6.

Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:225-60.

Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [see comments]. Nature. 388:394-7.

Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity. 12:121-7.

Poltorak, A., X. He, I. Smirnova, M.Y. Liu, C.V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:2085-8.

Qureshi, S.T., L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) [see comments] [published erratum appears in J Exp Med 1999 May 3;189(9):following 1518]. J Exp Med. 189:615-25.

Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 162:3749-52.

Wright, S.D., P.S. Tobias, R.J. Ulevitch, and R.A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med. 170:1231-41.

Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll- like receptor 4. J Exp Med. 189:1777-82.

Dinarello, C.A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8:253-65.

Dinarello, C.A. 1998. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci. 856:1-11.

Arend, W.P., M. Malyak, C.J. Guthridge, and C. Gabay. 1998. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 16:27-55.

Vigers, G.P.A., L.J. Anderson, P. Caffes, and B.J. Brandhuber. 1997. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1b. Nature. 386:190-194.

Schreuder, H., C. Tardif, S. Trump-Kallmeyer, A. Soffientini, E. Sarubbi, A. Akeson, T. Bowlin, S. Yanofsky, and R.W. Barrett. 1997. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 386:194-200.

Murphy, J.E., C. Robert, and T.S. Kupper. 2000. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol. 114:602-8.

Saklatvala, J., J. Dean, and A. Finch. 1999. Protein kinase cascades in intracellular signalling by interleukin-I and tumour necrosis factor. Biochem Soc Symp. 64:63-77.

Brightbill, H.D., D.H. Libraty, S.R. Krutzik, R.B. Yang, J.T. Belisle, J.R. Bleharski, M. Maitland, M.V. Norgard, S.E. Plevy, S.T. Smale, P.J. Brennan, B.R. Bloom, P.J. Godowski, and R.L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:732-6.

Mantovani, A., M. Muzio, P. Ghezzi, C. Colotta, and M. Introna. 1998. Regulation of inhibitory pathways of the interleukin-1 system. Ann N Y Acad Sci. 840:338-51.

Orlando, S., M. Sironi, G. Bianchi, A.H. Drummond, D. Boraschi, D. Yabes, and A. Mantovani. 1997. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem. 272:31764-9.

Colotta, F., S. Saccani, J.G. Giri, S.K. Dower, J.E. Sims, M. Introna, and A. Mantovani. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol. 156:2534-41.

Hannum, C.H., C.J. Wilcox, W.P. Arend, F.G. Joslin, D.J. Dripps, P.L. Heimdal, L.J. Armes, A. Sommer, S.P. Eisenberg, and R.C. Thompson. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Science. 343:336-340.

Henderson, B., R.C. Thompson, T. Hardingham, and J. Lewthwaite. 1991. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine. 3:246-249.

McIntyre, K.W., G.J. Stephan, K.D. Kolinsky, W.R. Benjamin, J.M. Plocinski, K.L. Kaffka, and P.L. Kilian. 1991. Inhibition of interleukin-1 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibodies. Journal of Experimental Medicine. 173:931-939.

Smith, D.R., S.L. Kunkel, T.J. Standiford, S.W. Chensue, M.W. Rolfe, M.B. Orringer, R.I. Whyte, M.D. Burdick, J.M. Danforth, A.R. Gilbert, and R.M. Strieter. 1993. The production of interleukin-1 receptor anatagonist protein by human bronchogenic carcinoma. American Journal of Pathology. In Press.

Lukacs, N.W., S.L. Kunkel, M.D. Burdick, P.M. Lincoln, and R.M. Strieter. 1993. Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction. Blood. 82:3668-3674.

Ulich, T.R., L.R. Watson, S.M. Yin, K.Z. Guo, P. Wang, H. Thang, and J. del Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced inflammatory infiltrate. American Journal of Pathology. 138:1485-96.

Fantuzzi, G., H. Zheng, R. Faggioni, F. Benigni, P. Ghezzi, J.D. Sipe, A.R. Shaw, and C.A. Dinarello. 1996. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol. 157:291-6.

Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N Engl J Med. 334:1717-25.

Genersch, E., K. Hayes, Y. Neuenfeld, H. Haller, N. Reunanen, J. Westermarck, L. Hakkinen, T.H. Holmstrom, I. Elo, J.E. Eriksson, and V.M. Kahari. 2000. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways

Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Cell Sci. 113:4319-4330.

Reunanen, N., J. Westermarck, L. Hakkinen, T.H. Holmstrom, I. Elo, J.E. Eriksson, and V.M. Kahari. 1998. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem. 273:5137-45.

Dehoux, M.S., A. Boutten, J. Ostinelli, N. Seta, M.C. Dombret, B. Crestani, M. Deschenes, J.L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 150:710-6.

van der Poll, T., C.V. Keogh, W.A. Buurman, and S.F. Lowry. 1997. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 155:603-8.

Takashima, K., K. Tateda, T. Matsumoto, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1997. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun. 65:257-60.

Laichalk, L.L., S.L. Kunkel, R.M. Strieter, J.M. Danforth, M.B. Bailie, and T.J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun. 64:5211-8.

Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun. 63:3272-8.

Brieland, J.K., D.G. Remick, P.T. Freeman, M.C. Hurley, J.C. Fantone, and N.C. Engleberg. 1995. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun. 63:3253-8.

Huffnagle, G.B., G.B. Toews, M.D. Burdick, M.B. Boyd, K.S. McAllister, R.A. McDonald, S.L. Kunkel, and R.M. Strieter. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol. 157:4529-36.

Mehrad, B., R.M. Strieter, and T.J. Standiford. 1999. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol. 162:1633-40.

Kolls, J.K., J.M. Beck, S. Nelson, W.R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol. 8:370-6.

Locati, M., and P.M. Murphy. 1999. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med. 50:425-40.

Hebert, C.A., R.V. Vitangcol, and J.B.B. JB. 1991. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem. 266:18989-94.

Clark-Lewis, I., C. Schumacher, M. Baggiolini, and B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs . Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding. J. Biol. Chem. 266:23128-23134.

Padrines, M., M. Wolf, A. Walz, and M. Baggiolini. 1994. Interleukin-8 processing by neutrophil elastase, cathepsin G, and proteinase-3. FEBS lett. 352:231-235.

Hebert, C.A., and J.B. Baker. 1993. Interleukin-8: a review. Cancer Invest. 11:743-50.

Walz, A., R.M. Strieter, and S. Schnyder. 1993. Neutrophil-activating peptide ENA-78. Adv. Exp. Med. Biol. 351:129-137.

De Meester, I., S. Korom, J. Van Damme, and S. Scharpe. 1999. CD26, let it cut or cut it down. Immunol Today. 20:367-75.

Proost, P., I. De Meester, D. Schols, S. Struyf, A.M. Lambeir, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpe, and J. Van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem. 273:7222-7.

Proost, P., P. Menten, S. Struyf, E. Schutyser, I. De Meester, and J. Van Damme. 2000. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood. 96:1674-80.

Iacovelli, L., M. Sallese, S. Mariggio, and A. de Blasi. 1999. Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. Faseb J. 13:1-8.

Sozzani, S., P. Allavena, A. Vecchi, and A. Mantovani. 2000. Chemokines and dendritic cell traffic [In Process Citation]. J Clin Immunol. 20:151-60.

Taub, D.D., J.R. Ortaldo, S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy. 1996. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol. 59:81-9.

Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:23-33.

Karpus, W.J., K.J. Kennedy, S.L. Kunkel, and N.W. Lukacs. 1998. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med. 187:733-41.

Gu, L., S. Tseng, R.M. Horner, C. Tam, M. Loda, and B.J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 404:407-11.

Boutten, A., M.S. Dehoux, N. Seta, J. Ostinelli, P. Venembre, B. Crestani, M.C. Dombret, G. Durand, and M. Aubier. 1996. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 153:336-42.

Rodriguez, J.L., C.G. Miller, L.E. DeForge, L. Kelty, C.J. Shanley, R.H. Bartlett, and D.G. Remick. 1992. Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma. 33:74-81; discussion 81-2.

Greenberger, M.J., R.M. Strieter, S.L. Kunkel, J.M. Danforth, L.L. Laichalk, D.C. McGillicuddy, and T.J. Standiford. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis. 173:159-65.

Standiford, T.J., S.L. Kunkel, M.J. Greenberger, L.L. Laichalk, and R.M. Strieter. 1996. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol. 59:24-8.

Standiford, T.J., R.M. Strieter, M.J. Greenberger, and S.L. Kunkel. 1996. Expression and regulation of chemokines in acute bacterial pneumonia. Biol Signals. 5:203-8.

Mehrad, B., and T.J. Standiford. 1999. Role of cytokines in pulmonary antimicrobial host defense. Immunol Res. 20:15-27.

Tsai, W.C., R.M. Strieter, J.M. Wilkowski, K.A. Bucknell, M.D. Burdick, S.A. Lira, and T.J. Standiford. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol. 161:2435-40.

Moore, T.A., M.W. Newstead, R.M. Strieter, B. Mehrad, B.L. Beaman, and T.J. Standiford. 2000. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J Immunol. 164:908-15.

Tsai, W.C., R.M. Strieter, B. Mehrad, M.W. Newstead, X. Zeng, and T.J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun. 68:4289-96.

Mehrad, B., R.M. Strieter, T.A. Moore, W.C. Tsai, S.A. Lira, and T.J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol. 163:6086-94.

Dawson, T.C., M.A. Beck, W.A. Kuziel, F. Henderson, and N. Maeda. 2000. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol. 156:1951-9.

Huffnagle, G.B., R.M. Strieter, T.J. Standiford, R.A. McDonald, M.D. Burdick, S.L. Kunkel, and G.B. Toews. 1995. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol. 155:4790-7.

Huffnagle, G.B., R.M. Strieter, L.K. McNeil, R.A. McDonald, M.D. Burdick, S.L. Kunkel, and G.B. Toews. 1997. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol. 159:318-27.

Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:2348-57.

Cher, D.J., and T.R. Mosmann. 1987. Two types of murine helper T cell clones. Delayed type hypersensitivity is mediated by Th1 clones. J Immunol 1991; 147-155. J. Immunol.:147-155.

Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the natural immune response? Immunol. Today. 13:379-381.

Swain, S.L., A.D. Weinberg, M. English, and G. Huston. 1990. IL-4 and IFN-g direct the development of distinct subsets of helper T cells. Fed. Proc. 4:2020-2024.

Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149-3155.

Gajewski, T., Joyce, J, Fitch, FW. 1989. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245-42-54.

Fiorentino, D.F., A. Zlotnik, and P. Viera. 1991. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 146:3444-3451.

Trinchieri, G., and P. Scott. 1994. The role of interleukin-12 in the immune response, disease and therapy. Immunol. Today. 15:460-467.

Chomarat, P., M. Rissoan, J. Banchereau, and P.P. Miossec. 1993. Interferon gamma inhibits interleukin-10 production by monocytes. J. Exp. Med. 177:523-534.

Akira, S. 2000. The role of IL-18 in innate immunity. Curr Opin Immunol. 12:59-63.

Werner, E.R., G. Werner-Felmayer, and H. Wachter. 1993. Tetrahydrobiopterin and cytokines. Proc Soc Exp Biol Med. 203:1-12.

Green, S.J., C.A. Nacy, and M.S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol. 50:93-103.

Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N Engl J Med. 329:2002-12.

Driggers, P.H., D.L. Ennist, S.L. Gleason, W.H. Mak, M.S. Marks, B.Z. Levi, J.R. Flanagan, E. Appella, and K. Ozato. 1990. An interferon gamma-regulated protein that binds the interferon- inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A. 87:3743-7.

Petroni, K.C., L. Shen, and P.M. Guyre. 1988. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J Immunol. 140:3467-72.

Dustin, M.L., and T.A. Springer. 1988. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol. 107:321-31.

Dustin, M.L., K.H. Singer, D.T. Tuck, and T.A. Springer. 1988. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med. 167:1323-40.

Freedman, A.S., G.J. Freeman, K. Rhynhart, and L.M. Nadler. 1991. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 137:429-37.

Roy, M., T. Waldschmidt, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol. 151:2497-510.

Farber, J.M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol. 61:246-57.

Rollins, B.J. 1997. Chemokines. Blood. 90:909-28.

Landolfo, S., F. Cofano, M. Giovarelli, M. Prat, G. Cavallo, and G. Forni. 1985. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science. 229:176-9.

Kitani, A., and W. Strober. 1993. Regulation of C gamma subclass germ-line transcripts in human peripheral blood B cells. J Immunol. 151:3478-88.

Sattar, S.A., M. Best, V.S. Springthorpe, and G. Sanani. 1995. Mycobactericidal testing of disinfectants: an update. J Hosp Infect. 30:372-82.

Mitscher, L.A., and W. Baker. 1998. Tuberculosis: a search for novel therapy starting with natural products. Med Res Rev. 18:363-74.

Palmieri, F., A.M. Pellicelli, E. Girardi, A.P. De Felici, P. De Mori, N. Petrosillo, and G. Ippolito. 1999. Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis. Infection. 27:331-4.

Ramaswamy, S., and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 79:3-29.

Cooper, A.M., D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 178:2243-7.

Flynn, J.L., J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 178:2249-54.

Condos, R., W.N. Rom, and N.W. Schluger. 1997. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [see comments]. Lancet. 349:1513-5.

de Waal Malefyt, R., H. Yssel, M.G. Roncarolo, H. Spits, and J.E. de Vries. 1992. Interleukin-10. Curr Opin Immunol. 4:314-20.

Moore, K.W., A. O’Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin-10. Annu Rev Immunol. 11:165-90.

Willems, F., A. Marchant, J.P. Delville, C. Gerard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 24:1007-9.

Kuga, S., T. Otsuka, H. Niiro, H. Nunoi, Y. Nemoto, T. Nakano, T. Ogo, T. Umei, and Y. Niho. 1996. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol. 24:151-7.

Flesch, I.E., and S.H. Kaufmann. 1994. Role of macrophages and alpha beta T lymphocytes in early interleukin 10 production during Listeria monocytogenes infection. Int Immunol. 6:463-8.

Houle, M., M. Thivierge, C. Le Gouill, J. Stankova, and M. Rola-Pleszczynski. 1999. IL-10 up-regulates CCR5 gene expression in human monocytes. Inflammation. 23:241-51.

Thivierge, M., J.L. Parent, J. Stankova, and M. Rola-Pleszczynski. 1999. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils. J Immunol. 162:3590-5.

Mulligan, M.S., M.L. Jones, A.A. Vaporciyan, M.C. Howard, and P.A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol. 151:5666-74.

Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 177:1205-8.

Standiford, T.J., R.M. Strieter, N.W. Lukacs, and S.L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol. 155:2222-9.

Greenberger, M.J., R.M. Strieter, S.L. Kunkel, J.M. Danforth, R.E. Goodman, and T.J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol. 155:722-9.